Genky DrugStores Co., Ltd. (TYO:9267)
4,575.00
-65.00 (-1.40%)
Aug 27, 2025, 2:44 PM JST
Genky DrugStores Cash Flow Statement
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 | Jun '21 Jun 20, 2021 | 2016 - 2020 |
Net Income | 9,902 | 8,803 | 6,704 | 6,083 | 6,662 | Upgrade |
Depreciation & Amortization | 6,292 | 5,566 | 4,955 | 4,592 | 4,058 | Upgrade |
Loss (Gain) From Sale of Assets | -2 | 287 | 376 | 8 | 56 | Upgrade |
Other Operating Activities | -3,155 | -1,895 | -2,043 | -2,004 | -1,645 | Upgrade |
Change in Accounts Receivable | -151 | -759 | -1,125 | -198 | -308 | Upgrade |
Change in Inventory | -3,042 | -1,603 | -1,579 | -1,522 | -1,102 | Upgrade |
Change in Accounts Payable | 2,877 | 2,197 | 1,799 | -129 | 3,552 | Upgrade |
Change in Other Net Operating Assets | -124 | 660 | -314 | -754 | 802 | Upgrade |
Operating Cash Flow | 12,597 | 13,256 | 8,773 | 6,076 | 12,075 | Upgrade |
Operating Cash Flow Growth | -4.97% | 51.10% | 44.39% | -49.68% | 62.93% | Upgrade |
Capital Expenditures | -15,092 | -10,278 | -9,891 | -10,464 | -8,812 | Upgrade |
Sale of Property, Plant & Equipment | 20 | - | 75 | 45 | - | Upgrade |
Sale (Purchase) of Intangibles | -15 | -163 | -37 | -43 | -142 | Upgrade |
Investment in Securities | - | -3 | - | 35 | - | Upgrade |
Other Investing Activities | -531 | -187 | 117 | -161 | 125 | Upgrade |
Investing Cash Flow | -15,618 | -10,631 | -9,736 | -10,588 | -8,829 | Upgrade |
Long-Term Debt Issued | 13,000 | 10,356 | 11,053 | 9,916 | 8,500 | Upgrade |
Total Debt Issued | 13,000 | 10,356 | 11,053 | 9,916 | 8,500 | Upgrade |
Long-Term Debt Repaid | -9,267 | -12,047 | -9,799 | -7,482 | -10,032 | Upgrade |
Total Debt Repaid | -9,267 | -12,047 | -9,799 | -7,482 | -10,032 | Upgrade |
Net Debt Issued (Repaid) | 3,733 | -1,691 | 1,254 | 2,434 | -1,532 | Upgrade |
Issuance of Common Stock | 17 | 27 | 3 | 13 | - | Upgrade |
Dividends Paid | -395 | -380 | -379 | -379 | -379 | Upgrade |
Other Financing Activities | -9 | -14 | -24 | -31 | -42 | Upgrade |
Financing Cash Flow | 3,346 | -2,058 | 854 | 2,037 | -1,953 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | -1 | 1 | 1 | -1 | Upgrade |
Net Cash Flow | 325 | 566 | -108 | -2,474 | 1,292 | Upgrade |
Free Cash Flow | -2,495 | 2,978 | -1,118 | -4,388 | 3,263 | Upgrade |
Free Cash Flow Margin | -1.24% | 1.61% | -0.66% | -2.84% | 2.29% | Upgrade |
Free Cash Flow Per Share | -81.92 | 97.91 | -36.79 | -144.36 | 107.39 | Upgrade |
Cash Interest Paid | 216 | 105 | 71 | 74 | 67 | Upgrade |
Cash Income Tax Paid | 3,155 | 1,792 | 2,042 | 1,987 | 1,635 | Upgrade |
Levered Free Cash Flow | -3,821 | 2,238 | -2,426 | -4,599 | 2,242 | Upgrade |
Unlevered Free Cash Flow | -3,686 | 2,302 | -2,382 | -4,562 | 2,276 | Upgrade |
Change in Working Capital | -440 | 495 | -1,219 | -2,603 | 2,944 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.